ophthalmologytimes16h
Anthony Wallace of Bausch + Lomb talks about enVista Envy FDA approval
The FDA granted approval to the enVista Envy full range of vision IOLs following Canadian approval in May 2024.
GlobalData on MSN17h
Bausch + Lomb wins FDA nod for enVista Envy range of intraocular lenses
The approval comes amidst rumours of a potential private equity buyout of the Canadian company, whose parent company has ...
Bausch + Lomb Shares Rise on FDA Approval of enVista Envy Intraocular Lens
Shares in Bausch + Lomb were higher after the company received approval from the Food and Drug Administration for its enVista Envy full range of vision intraocular lens. Shares were recently up 23% at ...
ophthalmologytimes23h
FDA approves Bausch + Lomb’s enVista Envy range of IOLs
According to the company, enVista Envy IOLs will be commercially available in the U.S. on a limited basis in the coming weeks ...
Bausch + Lomb : FDA Approves EnVista Envy Full Range Of Vision Intraocular Lens
Bausch + Lomb Corp. (BLCO, BLCO.TO) announced that the U.S. Food and Drug Administration has approved the enVista Envy full range of ...
The Cooper Companies: Winning Share In Contact Lens Markets
Cooper’s pricing power and cost optimization efforts are expected to drive margin expansion. Read why I reiterate a Buy ...